James L. Foght
Direktor/Vorstandsmitglied bei Oncolyze, Inc.
Profil
James L.
Foght is currently a Director at Oncolyze, Inc. He previously held positions as Chairman at PharmaIN Corp., Director at Orchestra Therapeutics, Inc., MedImmune Ltd., and Pinnacle Biologics, Inc. He was also a Director at Acrux Ltd.
and African Wildlife Foundation, Inc. He served as Principal at Kidd & Co. LLC from 2007 to 2010 and was a Senior Vice President at Kidder Peabody & Co., Inc. He was an Investment Committee Member at Illinois Ventures LLC and Vector Asset Management, Inc. from 1999 to 2007.
Foght received his undergraduate degree from the University of Akron and his graduate and doctorate degrees from the University of Illinois.
Aktive Positionen von James L. Foght
| Unternehmen | Position | Beginn |
|---|---|---|
Oncolyze, Inc.
 Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von James L. Foght
| Unternehmen | Position | Ende |
|---|---|---|
Kidd & Co. LLC
 Kidd & Co. LLC Investment ManagersFinance Kidd & Co. LLC (Kidd) is a private equity firm founded in 1976 by William J. Kidd. The firm is headquartered in Old Greenwich, Connecticut. | Private Equity Investor | 31.08.2010 |
Vector Asset Management, Inc.
 Vector Asset Management, Inc. Investment ManagersFinance Vector Asset Management, Inc. is a venture capital firm based in Deerfield, Illinois | Mitglied des Investmentausschusses | 01.11.2007 |
| ACRUX LIMITED | Direktor/Vorstandsmitglied | 03.07.2006 |
Kidder Peabody & Co., Inc. /Non Retail Unit/
 Kidder Peabody & Co., Inc. /Non Retail Unit/ Investment Banks/BrokersFinance Part of UBS Group AG, Kidder Peabody & Co., Inc. /Non Retail Unit/ is a security brokers & dealers. The company is based in Staten Island, NY. | Corporate Officer/Principal | 30.06.1999 |
Pinnacle Biologics, Inc.
 Pinnacle Biologics, Inc. Medical/Nursing ServicesHealth Services Pinnacle Biologics, Inc. specializes in revitalizing healthcare therapies by developing approaches to the global commercialization of products. It engages in assisting pharmaceutical and biotech companies in providing full portfolio of services aimed at the commercialization or continuation. The company was founded by Viren Grover, Guillermo A. Herrera and James R. Miller in 2007 and is headquartered in Chicago, IL. | Direktor/Vorstandsmitglied | - |
Ausbildung von James L. Foght
| University of Illinois | Doctorate Degree |
| University of Akron | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ACRUX LIMITED | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Vector Asset Management, Inc.
Vector Asset Management, Inc. Investment ManagersFinance Vector Asset Management, Inc. is a venture capital firm based in Deerfield, Illinois | Finance |
Kidder Peabody & Co., Inc. /Non Retail Unit/
Kidder Peabody & Co., Inc. /Non Retail Unit/ Investment Banks/BrokersFinance Part of UBS Group AG, Kidder Peabody & Co., Inc. /Non Retail Unit/ is a security brokers & dealers. The company is based in Staten Island, NY. | Finance |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Orchestra Therapeutics, Inc.
 Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Finance |
PharmaIN Corp.
 PharmaIN Corp. Pharmaceuticals: MajorHealth Technology PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA. | Health Technology |
Illinois Ventures LLC
 Illinois Ventures LLC Investment ManagersFinance Illinois Ventures LLC (Illinois Ventures) is a venture capital firm founded in 2000. The firm is headquartered in Champaign, Illinois. | Finance |
Kidd & Co. LLC
Kidd & Co. LLC Investment ManagersFinance Kidd & Co. LLC (Kidd) is a private equity firm founded in 1976 by William J. Kidd. The firm is headquartered in Old Greenwich, Connecticut. | Finance |
African Wildlife Foundation, Inc.
 African Wildlife Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services African Wildlife Foundation, Inc. operates an international conservation organization focused on the African continent. The organization programs and conservation strategies are based on science and designed to protect both the wild lands and wildlife of Africa. The organization was founded in 1961 and is headquartered in Washington, DC. | Commercial Services |
Pinnacle Biologics, Inc.
Pinnacle Biologics, Inc. Medical/Nursing ServicesHealth Services Pinnacle Biologics, Inc. specializes in revitalizing healthcare therapies by developing approaches to the global commercialization of products. It engages in assisting pharmaceutical and biotech companies in providing full portfolio of services aimed at the commercialization or continuation. The company was founded by Viren Grover, Guillermo A. Herrera and James R. Miller in 2007 and is headquartered in Chicago, IL. | Health Services |
Oncolyze, Inc.
Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation. | Health Technology |
